Home Thomson StreetEvents

Exelixis Inc at TD Cowen Oncology Innovation Summit (Virtual) Transcript

Published May 27, 2025

11 pages (6530 words) — Published May 27, 2025

Price US$ 54.00 | Buy this Report Now

About This Report

Abstract:

Edited Transcript of EXEL.OQ presentation 27-May-25 6:30pm GMT

Brief Excerpt:

...Well, good afternoon, everybody, and thank you once again for joining us for the Sixth annual Oncology Innovation Summit. I'm Yaron Werber from the TD Cowen Biotech team. And it's a great pleasure to have with us today, really needs the introduction, Andrew Peters, Senior Vice President of Strategy, and a former very well esteemed a Wall Streeter. So Andrew, thanks for joining. We appreciate it. Andrew Peters ...

Report Type:

Transcript

Source:

Thomson StreetEvents

Company:

Exelixis Inc

Ticker

EXEL.OQ

Time

6:30pm GMT

Format:

PDF

Exelixis Inc at William Blair Growth Stock Conference Summary – 2025-06-03 – US$ 54.00 – Edited Brief of EXEL.OQ presentation 3-Jun-25 3:00pm GMT

Exelixis Inc at William Blair Growth Stock Conference Transcript – 2025-06-03 – US$ 54.00 – Edited Transcript of EXEL.OQ presentation 3-Jun-25 3:00pm GMT

Exelixis Inc Annual Shareholders Meeting Summary – 2025-05-28 – US$ 54.00 – Edited Brief of EXEL.OQ shareholder or annual meeting 28-May-25 4:00pm GMT

Exelixis Inc Annual Shareholders Meeting Transcript – 2025-05-28 – US$ 54.00 – Edited Transcript of EXEL.OQ shareholder or annual meeting 28-May-25 4:00pm GMT

Exelixis Inc at TD Cowen Oncology Innovation Summit (Virtual) Summary – 2025-05-27 – US$ 54.00 – Edited Brief of EXEL.OQ presentation 27-May-25 6:30pm GMT

Exelixis Inc at RBC Capital Markets Global Healthcare Conference Summary – 2025-05-20 – US$ 54.00 – Edited Brief of EXEL.OQ presentation 20-May-25 2:30pm GMT

Exelixis Inc at RBC Capital Markets Global Healthcare Conference Transcript – 2025-05-20 – US$ 54.00 – Edited Transcript of EXEL.OQ presentation 20-May-25 2:30pm GMT

Exelixis Inc Q1 2025 Earnings Call Summary – 2025-05-13 – US$ 54.00 – Edited Brief of EXEL.OQ earnings conference call or presentation 13-May-25 9:00pm GMT

Exelixis Inc Q1 2025 Earnings Call Transcript – 2025-05-13 – US$ 54.00 – Edited Transcript of EXEL.OQ earnings conference call or presentation 13-May-25 9:00pm GMT

Exelixis Inc at Leerink Partners Global Healthcare Conference Summary – 2025-03-12 – US$ 54.00 – Edited Brief of EXEL.OQ presentation 12-Mar-25 2:40pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author

Cite this Report


MLA:	Thomson StreetEvents. "Exelixis Inc at TD Cowen Oncology Innovation Summit (Virtual) Transcript" May 27, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Exelixis-Inc-at-TD-Cowen-Oncology-Innovation-Summit-Virtual-T16389032>

APA:	Thomson StreetEvents. (2025). Exelixis Inc at TD Cowen Oncology Innovation Summit (Virtual) Transcript May 27, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Exelixis-Inc-at-TD-Cowen-Oncology-Innovation-Summit-Virtual-T16389032>

US$ 54.00

$ £ €

Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

Example Report

Click to View Sample Report

More Research

Search all our Credit Research from one place.